-
2
-
-
42149142899
-
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
-
10.2174/156720508783884576. 18288936
-
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. AP Porsteinsson GT Grossberg J Mintzer JT Olin Memantine MEM-MD-12 Study Group, Curr Alzheimer Res 2008 5 83 89 10.2174/156720508783884576 18288936
-
(2008)
Curr Alzheimer Res
, vol.5
, pp. 83-89
-
-
Porsteinsson, A.P.1
Grossberg, G.T.2
Mintzer, J.3
Olin, J.T.4
-
3
-
-
69549105254
-
Ginkgo biloba for cognitive impairment and dementia
-
19160216
-
Ginkgo biloba for cognitive impairment and dementia. J Birks J Grimley Evans, Cochrane Database Syst Rev 2009 1 D003120 19160216
-
(2009)
Cochrane Database Syst Rev
, vol.1
-
-
Birks, J.1
Grimley Evans, J.2
-
4
-
-
33747823312
-
Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study
-
10.1111/j.1468-1331.2006.01409.x. 16930364
-
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. M Mazza A Capuano P Bria S Mazza, Eur J Neurol 2006 13 981 985 10.1111/j.1468-1331.2006. 01409.x 16930364
-
(2006)
Eur J Neurol
, vol.13
, pp. 981-985
-
-
Mazza, M.1
Capuano, A.2
Bria, P.3
Mazza, S.4
-
5
-
-
73949086506
-
Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial
-
10.1001/jama.2009.1913. 20040554
-
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. BE Snitz ES O'Meara MC Carlson AM Arnold DG Ives SR Rapp J Saxton OL Lopez LO Dunn KM Sink ST DeKosky Ginkgo Evaluation of Memory Study I, JAMA 2009 302 2663 2670 10.1001/jama.2009.1913 20040554
-
(2009)
JAMA
, vol.302
, pp. 2663-2670
-
-
Snitz, B.E.1
O'Meara, E.S.2
Carlson, M.C.3
Arnold, A.M.4
Ives, D.G.5
Rapp, S.R.6
Saxton, J.7
Lopez, O.L.8
Dunn, L.O.9
Sink, K.M.10
Dekosky, S.T.11
-
7
-
-
0037173785
-
Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial [in Chinese]
-
12181083
-
Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial [in Chinese]. Z Zhang X Wang Q Chen L Shu J Wang G Shan, Zhonghua Yi Xue Za Zhi 2002 82 941 944 12181083
-
(2002)
Zhonghua Yi Xue Za Zhi
, vol.82
, pp. 941-944
-
-
Zhang, Z.1
Wang, X.2
Chen, Q.3
Shu, L.4
Wang, J.5
Shan, G.6
-
8
-
-
33845672995
-
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides
-
10.1096/fj.05-5530fje. 16636099
-
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides. F Chen EA Eckman CB Eckman, Faseb J 2006 20 1269 1271 10.1096/fj.05-5530fje 16636099
-
(2006)
Faseb J
, vol.20
, pp. 1269-1271
-
-
Chen, F.1
Eckman, E.A.2
Eckman, C.B.3
-
9
-
-
77951437216
-
A systematic review of single Chinese herbs for Alzheimer's disease treatment
-
A systematic review of single Chinese herbs for Alzheimer's disease treatment. LM Fu JT Li, Evid Based Complement Alternat Med 2009
-
(2009)
Evid Based Complement Alternat Med
-
-
Fu, L.M.1
Li, J.T.2
-
10
-
-
70350490843
-
Ginseng for cognitive function in Alzheimer's disease: A systematic review
-
19584437
-
Ginseng for cognitive function in Alzheimer's disease: a systematic review. MS Lee EJ Yang JI Kim E Ernst, J Alzheimers Dis 2009 18 339 344 19584437
-
(2009)
J Alzheimers Dis
, vol.18
, pp. 339-344
-
-
Lee, M.S.1
Yang, E.J.2
Kim, J.I.3
Ernst, E.4
-
11
-
-
0037293995
-
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial
-
DOI 10.1046/j.1365-2710.2003.00463.x
-
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebocontrolled trial. S Akhondzadeh M Noroozian M Mohammadi S Ohadinia AH Jamshidi M Khani, J Clin Pharm Ther 2003 28 53 59 10.1046/j.1365-2710.2003.00463.x 12605619 (Pubitemid 36313176)
-
(2003)
Journal of Clinical Pharmacy and Therapeutics
, vol.28
, Issue.1
, pp. 53-59
-
-
Akhondzadeh, S.1
Noroozian, M.2
Mohammadi, M.3
Ohadinia, S.4
Jamshidi, A.H.5
Khani, M.6
-
12
-
-
36148991145
-
Clinical study on a randomized, doubleblind control of Shenwu gelatin capsule in treatment of mild cognitive impairment [in Chinese]
-
17993008
-
Clinical study on a randomized, doubleblind control of Shenwu gelatin capsule in treatment of mild cognitive impairment [in Chinese]. J Zhong JZ Tian AH Zhu CZ Yang, Zhongguo Zhong Yao Za Zhi 2007 32 1800 1803 17993008
-
(2007)
Zhongguo Zhong Yao Za Zhi
, vol.32
, pp. 1800-1803
-
-
Zhong, J.1
Tian, J.Z.2
Zhu, A.H.3
Yang, C.Z.4
-
13
-
-
64549087197
-
GEPT extract reduces a beta deposition by regulating the balance between production and degradation of amyloid-beta in APPV717I transgenic mice
-
10.2174/156720509787602942. 19355846
-
GEPT extract reduces a beta deposition by regulating the balance between production and degradation of amyloid-beta in APPV717I transgenic mice. J Tian J Shi L Zhang J Yin Q Hu Y Xu S Sheng P Wang Y Ren R Wang Y Wang, Curr Alzheimer Res 2009 6 118 131 10.2174/156720509787602942 19355846
-
(2009)
Curr Alzheimer Res
, vol.6
, pp. 118-131
-
-
Tian, J.1
Shi, J.2
Zhang, L.3
Yin, J.4
Hu, Q.5
Xu, Y.6
Sheng, S.7
Wang, P.8
Ren, Y.9
Wang, R.10
Wang, Y.11
-
14
-
-
78049275680
-
Part 5: A randomized, double-blind and parallel control study of GEPT extract in the treatment of amnestic mild cognitive impairment
-
Beijing University of Chinese Medicine
-
Part 5: a randomized, double-blind and parallel control study of GEPT extract in the treatment of amnestic mild cognitive impairment. YC Miao, PhD thesis Beijing University of Chinese Medicine 2008 95 117
-
(2008)
PhD Thesis
, pp. 95-117
-
-
Miao, Y.C.1
-
15
-
-
4444309296
-
A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine 'Ba wei di huang wan' in the treatment of dementia
-
10.1111/j.1532-5415.2004.52415.x. 15341554
-
A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine 'Ba wei di huang wan' in the treatment of dementia. K Iwasaki S Kobayashi Y Chimura M Taguchi K Inoue S Cho T Akiba H Arai JC Cyong H Sasaki, J Am Geriatr Soc 2004 52 1518 1521 10.1111/j.1532-5415.2004.52415.x 15341554
-
(2004)
J Am Geriatr Soc
, vol.52
, pp. 1518-1521
-
-
Iwasaki, K.1
Kobayashi, S.2
Chimura, Y.3
Taguchi, M.4
Inoue, K.5
Cho, S.6
Akiba, T.7
Arai, H.8
Cyong, J.C.9
Sasaki, H.10
-
16
-
-
20044382588
-
A randomized, observerblind, controlled trial of the traditional Chinese medicine yi-gan san for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients
-
10.4088/JCP.v66n0214. 15705012
-
A randomized, observerblind, controlled trial of the traditional Chinese medicine yi-gan san for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. K Iwasaki T Satoh-Nakagawa M Maruyama Y Monma M Nemoto N Tomita H Tanji H Fujiwara T Seki M Fujii H Arai H Sasaki, J Clin Psychiatry 2005 66 248 252 10.4088/JCP.v66n0214 15705012
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 248-252
-
-
Iwasaki, K.1
Satoh-Nakagawa, T.2
Maruyama, M.3
Monma, Y.4
Nemoto, M.5
Tomita, N.6
Tanji, H.7
Fujiwara, H.8
Seki, T.9
Fujii, M.10
Arai, H.11
Sasaki, H.12
-
17
-
-
52649150959
-
Panax ginseng enhances cognitive performance in Alzheimer disease
-
10.1097/WAD.0b013e31816c92e6. 18580589
-
Panax ginseng enhances cognitive performance in Alzheimer disease. ST Lee K Chu JY Sim JH Heo M Kim, Alzheimer Dis Assoc Disord 2008 22 222 226 10.1097/WAD.0b013e31816c92e6 18580589
-
(2008)
Alzheimer Dis Assoc Disord
, vol.22
, pp. 222-226
-
-
Lee, S.T.1
Chu, K.2
Sim, J.Y.3
Heo, J.H.4
Kim, M.5
|